MoonLake Immunotherapeutics (MLTX) stock
MLTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$10.79−0.46 (-4.09%)
Close on Nov 18, 2026Market cap $918.30MP/E –Yield –
MoonLake Immunotherapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
MoonLake Immunotherapeutics's pe ratio was 255.5× on Oct 31, 2022.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Oct 31, 2022 | 255.5× | – |
See a number that looks wrong?